Schaffzin Joshua K, Dodd Caitlin N, Nguyen Hovi, Schondelmeyer Amanda, Campanella Suzanne, Goldstein Stuart L
Divisions of Hospital Medicine.
Hosp Pediatr. 2014 May;4(3):159-66. doi: 10.1542/hpeds.2013-0116.
Nephrotoxin exposure is a common cause of acute kidney injury (AKI) in hospitalized children. AKI detection relies on regular serum creatinine (SCr) screening among exposed patients. We sought to determine how well administrative data identify hospitalized noncritically ill children with nephrotoxic medication-associated AKI in the contexts of incomplete and complete screening.
We conducted a single-center retrospective cohort study among noncritically ill hospitalized children. We compared administrative data sensitivity to that among a separate cohort for whom adequate screening was defined as daily SCr measurement. For the original cohort, nephrotoxin exposure was defined as exposure to ≥3 nephrotoxins at once or ≥3 days of aminoglycoside therapy. AKI was defined by the change in SCr (pediatric-modified Risk Injury Failure Loss End-Stage Renal Disease [pRIFLE] criteria) or discharge code. Adequate SCr screening was defined as 2 measurements obtained ≤96 hours apart. Administrative data and laboratory values were merged to compare AKI by discharge code and pRIFLE criteria.
747 of 1472 (50.7%) nephrotoxin-exposed patients were adequately screened; 82 (11.0%) had AKI by pRIFLE criteria, 52 (7.0%) by discharge code. Sensitivity of nephrotoxin-associated AKI diagnosis by discharge code compared with pRIFLE criteria was 23.2% (95% confidence interval = 14.0-32.3). In the comparison cohort, 70 (26.8%) patients had AKI by pRIFLE criteria and 26 (10.0%) by discharge code; sensitivity was 21.4% (95% confidence interval = 11.8%-31.0%).
pRIFLE criteria identified more patients than were identified by discharge code. Identifying patients with nephrotoxin-associated AKI by discharge code, even in the presence of complete AKI detection, underrepresents the true incidence of nephrotoxin-associated AKI in hospitalized children.
肾毒素暴露是住院儿童急性肾损伤(AKI)的常见病因。AKI的检测依赖于对暴露患者定期进行血清肌酐(SCr)筛查。我们试图确定在筛查不完整和完整的情况下,管理数据在识别因肾毒性药物相关AKI而住院的非危重症儿童方面的效果如何。
我们对非危重症住院儿童进行了一项单中心回顾性队列研究。我们将管理数据的敏感性与另一个队列进行比较,在该队列中,充分筛查被定义为每日测量SCr。对于原始队列,肾毒素暴露被定义为一次暴露于≥3种肾毒素或接受≥3天的氨基糖苷类治疗。AKI根据SCr的变化(儿童改良的风险、损伤、衰竭、失功、终末期肾病[pRIFLE]标准)或出院诊断代码来定义。充分的SCr筛查被定义为在≤96小时内进行2次测量。合并管理数据和实验室值,以根据出院诊断代码和pRIFLE标准比较AKI。
1472例肾毒素暴露患者中有747例(50.7%)接受了充分筛查;根据pRIFLE标准,82例(11.0%)发生AKI,根据出院诊断代码,52例(7.0%)发生AKI。与pRIFLE标准相比,出院诊断代码诊断肾毒素相关AKI的敏感性为23.2%(95%置信区间=14.0-32.3)。在比较队列中,根据pRIFLE标准,70例(26.8%)患者发生AKI,根据出院诊断代码,26例(10.0%)发生AKI;敏感性为21.4%(95%置信区间=11.8%-31.0%)。
pRIFLE标准识别出的患者比出院诊断代码识别出的更多。即使在AKI检测完整的情况下,通过出院诊断代码识别肾毒素相关AKI患者也低估了住院儿童肾毒素相关AKI的真实发病率。